egtazic acid has been researched along with Hyperlipemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cameron, SJ; Cooley, BC; Jobe, SM; Kholmukhamedov, A; Morrell, CN; Schulte, ML; Scoggins, NO; Silverstein, RL; Wood, JP; Yang, M | 1 |
1 other study(ies) available for egtazic acid and Hyperlipemia
Article | Year |
---|---|
Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Topics: Animals; Blood Platelets; Caspases; CD36 Antigens; Crotalid Venoms; Diet, High-Fat; Disease Models, Animal; Egtazic Acid; Fibrin; Humans; Hyperlipidemias; Lectins, C-Type; Lipoproteins, LDL; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 7; Phosphatidylserines; Platelet Activation; Signal Transduction; src-Family Kinases; Thrombosis | 2018 |